YU69693A - Transdermalni terapijski sistem sa aktivnom materijom estradiol - Google Patents

Transdermalni terapijski sistem sa aktivnom materijom estradiol

Info

Publication number
YU69693A
YU69693A YU69693A YU69693A YU69693A YU 69693 A YU69693 A YU 69693A YU 69693 A YU69693 A YU 69693A YU 69693 A YU69693 A YU 69693A YU 69693 A YU69693 A YU 69693A
Authority
YU
Yugoslavia
Prior art keywords
estradiol
adhesive layer
matrix layers
active material
therapy system
Prior art date
Application number
YU69693A
Other languages
English (en)
Inventor
M. Horstmann
S. Hahn
R. Meconi
R.P. Klein
Original Assignee
Lts. Lohmann Therapie - Sisteme Gmbh. And Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6472230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU69693(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts. Lohmann Therapie - Sisteme Gmbh. And Co.Kg. filed Critical Lts. Lohmann Therapie - Sisteme Gmbh. And Co.Kg.
Publication of YU69693A publication Critical patent/YU69693A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

TRANSDERMALNI TERAPIJSKI SISTEM SA AKTIVNOM MATERIJOM ESTRADIOL - pronalazak se odnosi na transdermalni terapijski sistem koji sadrži aktivnu materiju 17-beta-estradiol i u datom slucaju dalje aktivne materije, sa slojevitom izradom iz zadnjeg sloja u suštini nepropusnog za vlagu kao i nepropusnog za aktivnu materiju, jednog ili vise slojeva matrice i pri prisustvu nalepljivih slojeva matrice lepljivog sloja, koji je naznačen time, sto koncentracija rastvorenog estradiola u svim slojevima matrice i pri prisustvu lepljivog sloja u ovom leži izmedju njegove koncentracije zasićenja u suvom stanju i njegove koncentracije u vlažnom stanju, pri čemu se pod pojmom "suvo stanje" podrazumeva, da osnovni materijal stoji u ravnoteži sa gasnom fazom sa manje od 10% relativne vlažnosti vazduha i pod pojmom "vlažno stanje", da osnovni materijal stoji u ravnoteži prema gasnoj fazi sa vise od 90% relativne vlažnosti vazduha.
YU69693A 1992-11-06 1993-11-03 Transdermalni terapijski sistem sa aktivnom materijom estradiol YU69693A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237453A DE4237453C1 (sh) 1992-11-06 1992-11-06

Publications (1)

Publication Number Publication Date
YU69693A true YU69693A (sh) 1997-07-31

Family

ID=6472230

Family Applications (1)

Application Number Title Priority Date Filing Date
YU69693A YU69693A (sh) 1992-11-06 1993-11-03 Transdermalni terapijski sistem sa aktivnom materijom estradiol

Country Status (24)

Country Link
US (1) US5912008A (sh)
EP (1) EP0716599B1 (sh)
JP (1) JP3237016B2 (sh)
KR (1) KR100306946B1 (sh)
AT (1) ATE164516T1 (sh)
AU (1) AU678408B2 (sh)
CA (1) CA2147172C (sh)
CZ (1) CZ286907B6 (sh)
DE (2) DE4237453C1 (sh)
DK (1) DK0716599T3 (sh)
ES (1) ES2117152T3 (sh)
FI (1) FI113339B (sh)
HR (1) HRP931360B1 (sh)
HU (1) HU221847B1 (sh)
IL (1) IL107395A (sh)
MY (1) MY118171A (sh)
NO (1) NO311783B1 (sh)
NZ (1) NZ257137A (sh)
PL (1) PL174604B1 (sh)
SI (1) SI9300581A (sh)
SK (1) SK279911B6 (sh)
WO (1) WO1994010984A1 (sh)
YU (1) YU69693A (sh)
ZA (1) ZA938257B (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
DK0695177T3 (da) * 1993-04-20 1998-09-28 Hexal Ag Plaster indeholdende aktivt stof
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
US6631186B1 (en) * 1999-04-09 2003-10-07 Sbc Technology Resources, Inc. System and method for implementing and accessing call forwarding services
DE19925613A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
ITRM20060440A1 (it) * 2006-08-10 2008-02-11 Carmine Antropoli Uso della nifedipina per il trattamento antirughe
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
KR102495101B1 (ko) 2014-07-11 2023-02-02 노반, 인크. 국소 항바이러스 조성물 및 그의 사용 방법
BR112018070578A2 (pt) 2016-04-13 2019-02-12 Novan, Inc. composições, sistemas, kits, e métodos para tratar uma infecção
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR527450A (fr) * 1919-12-04 1921-10-25 Gilbert Mahaut Système et dispositif pour la combustion des huiles lourdes dans les foyers industriels et autres
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1990009784A1 (en) * 1989-02-28 1990-09-07 Teijin Limited Poultice and preparation thereof
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations

Also Published As

Publication number Publication date
SI9300581A (en) 1994-06-30
CZ286907B6 (en) 2000-08-16
SK279911B6 (sk) 1999-05-07
JPH08502987A (ja) 1996-04-02
IL107395A (en) 1997-08-14
PL174604B1 (pl) 1998-08-31
JP3237016B2 (ja) 2001-12-10
WO1994010984A1 (de) 1994-05-26
NO951765L (no) 1995-05-05
ATE164516T1 (de) 1998-04-15
HU221847B1 (hu) 2003-02-28
FI113339B (fi) 2004-04-15
CA2147172A1 (en) 1994-05-26
EP0716599A1 (de) 1996-06-19
SK58095A3 (en) 1995-11-08
HRP931360A2 (en) 1995-02-28
DK0716599T3 (da) 1999-01-11
FI952115A (fi) 1995-05-03
NO311783B1 (no) 2002-01-28
DE59308360D1 (de) 1998-05-07
HRP931360B1 (en) 1999-12-31
US5912008A (en) 1999-06-15
EP0716599B1 (de) 1998-04-01
PL308532A1 (en) 1995-08-21
CA2147172C (en) 2003-12-23
MY118171A (en) 2004-09-30
CZ116295A3 (en) 1995-12-13
FI952115A0 (fi) 1995-05-03
IL107395A0 (en) 1994-01-25
HU9501318D0 (en) 1995-06-28
HUT71681A (en) 1996-01-29
ZA938257B (en) 1994-06-08
ES2117152T3 (es) 1998-08-01
KR100306946B1 (ko) 2002-04-24
KR950703940A (ko) 1995-11-17
NO951765D0 (no) 1995-05-05
DE4237453C1 (sh) 1993-08-19
AU678408B2 (en) 1997-05-29
AU5338694A (en) 1994-06-08
NZ257137A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
YU69693A (sh) Transdermalni terapijski sistem sa aktivnom materijom estradiol
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
NO950047L (no) Transdermalt terapeutisk system inneholdende det aktive stoffet 17-beta-östradiol
NZ325817A (en) Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-beta-estradiol to the human organism
YU49193A (sh) Transdermalni terapijski sistem sa aktivnom materijom bezvodnim 17-beta-estradiolom